Research presented at the European Congress on Obesity reports that weight-loss injections can reduce workplace sickness and lower the need for medical follow-up. One study described in coverage finds that more than 60% of participants did not need to contact their GP at all after nine months of treatment. The reporting also says the injections halve sickness-related days, implying fewer short-term illnesses or health flare-ups that lead people to stay home from work. The outlets add that these effects could translate into wider healthcare benefits, including freeing up GP appointment capacity and easing pressure on other services such as hospital Accident & Emergency departments, though the evidence cited focuses on participants’ healthcare use rather than direct measurements of system-wide changes. Overall, the sources present the results as potential knock-on benefits from improved weight management, with the main outcomes described being reduced GP contact and reduced sickness absence after several months of injections.